Effects of Sirrah-Bios PRRSV-RS vaccine on mortality rate and finisher pig performance

dc.citation.epage37en_US
dc.citation.spage33en_US
dc.contributor.authorPotter, M. L.
dc.contributor.authorHenry, Steven C.
dc.contributor.authorTokach, Lisa M.
dc.contributor.authorDeRouchey, Joel M.
dc.contributor.authorTokach, Michael D.
dc.contributor.authorGoodband, Robert D.
dc.contributor.authorNelssen, Jim L.
dc.contributor.authorDritz, Steven S.
dc.contributor.authoreiddritzen_US
dc.contributor.authoreidjderouchen_US
dc.contributor.authoreidmtokachen_US
dc.contributor.authoreidgoodbanden_US
dc.contributor.authoreidjnelssenen_US
dc.date.accessioned2009-11-12T18:59:31Z
dc.date.available2009-11-12T18:59:31Z
dc.date.issued2009-11-12T18:59:31Z
dc.date.published2009en_US
dc.description.abstractA total of 1,561 pigs (initially 4 d of age) were used to determine the effects of a porcine reproductive and respiratory syndrome virus (PRRSv) subunit vaccine, PRRSV-RS (Sirrah-Bios, Ames, IA), on mortality rate and finisher pig growth performance in a PRRSv-positive commercial herd. Pigs were randomly assigned by litter to either the subunit PRRSv vaccine or non-vaccinated control group. Pigs in the vaccinated group received an intramuscular injection of 1 mL PRRSV-RS vaccine at processing (approximately 4 d after birth) and again at weaning (approximately 24 d of age). Vaccinated and control pigs were comingled in a single nursery during the nursery phase. In the finishing phase, pigs were housed in a standard commercial curtain-sided finisher barn by treatment and gender by pen, with treatments randomly distributed across pens. Mortality was tracked from processing (4 d of age) to market (d 187 to 193). There was no difference between the control and vaccinated pigs for cumulative mortality (21.5% vs. 20.6%, P = 0.67) or for mortality during each production phase (processing to weaning: 9.5% vs. 7.1%, P = 0.08; nursery: 9.3% vs. 9.2%, P = 0.95; finishing: 4.4% vs. 5.9%, P = 0.20). Pigs were initially weighed by single-sex pens (control or vaccinated) 2 wk after placement into the finisher (d 0), and at that time, control and vaccinated mean pig weights were not different (58.4 vs. 58.7 lb, P = 0.90). Pens of pigs were subsequently weighed every 2 wk, and feed consumption was recorded to calculate ADG, ADFI, and F/G. Overall (d 0 to 112), control and vaccinated pig performance was similar (ADG: 1.96 vs. 1.93 lb, P = 0.45; ADFI: 5.35 vs. 5.36 lb, P = 0.94; F/G: 2.74 vs. 2.78, P = 0.15) throughout the finishing period. This resulted in no difference (P = 0.79) in off-test (d 112) weights between control (271.9 lb) and vaccinated (270.4 lb) pigs. These data indicate that this subunit PRRSv vaccine did not affect finisher pig performance or mortality in this commercial herd.en_US
dc.description.conferenceSwine Day, Manhattan, KS, November 19, 2009en_US
dc.identifier.urihttp://hdl.handle.net/2097/2149
dc.publisherKansas State University. Agricultural Experiment Station and Cooperative Extension Serviceen_US
dc.relation.isPartOfSwine day, 2009en_US
dc.relation.isPartOfKansas Agricultural Experiment Station contribution; no. 10-014-Sen_US
dc.relation.isPartOfReport of progress (Kansas State University. Agricultural Experiment Station and Cooperative Extension Service); 1020en_US
dc.subjectGrowthen_US
dc.subjectMortalityen_US
dc.subjectPRRSven_US
dc.subjectVaccineen_US
dc.subjectSwineen_US
dc.titleEffects of Sirrah-Bios PRRSV-RS vaccine on mortality rate and finisher pig performanceen_US
dc.typeConference paperen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Effects of Sirrah-Bios PRRSV-RS Vaccine on Mortality Rate.pdf
Size:
208.04 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections